<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02154750</url>
  </required_header>
  <id_info>
    <org_study_id>130663</org_study_id>
    <nct_id>NCT02154750</nct_id>
  </id_info>
  <brief_title>AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals</brief_title>
  <acronym>AV Delay</acronym>
  <official_title>Evaluation of AV Delay Optimization vs. Intrinsic Conduction in Patients With Long PR Intervals Receiving Dual Chamber Pacemakers for Symptomatic Bradycardia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, prospective clinical trial to determine the effects of two different&#xD;
      pacemaker atrioventricular delay (AV delay) settings on heart function in patients with dual&#xD;
      chamber pacemakers implanted for symptomatic bradycardia with long PR intervals (delayed&#xD;
      conduction between upper and lower chambers of the heart). The study will compare a long,&#xD;
      fixed AV delay (standard) with an optimized AV delay for each individual using&#xD;
      echocardiography (experimental).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac pacing is the only effective treatment for symptomatic sinus node dysfunction. Most&#xD;
      patients with preserved left ventricular function receive dual chamber pacemakers; however,&#xD;
      right ventricular pacing can have detrimental effects on left ventricular function due to the&#xD;
      abnormal electrical and mechanical activation pattern of the ventricles.&#xD;
&#xD;
      Many patients receiving dual chamber pacemakers for symptomatic bradycardia have prolonged&#xD;
      intrinsic AV conduction (first degree AV block), and as a result, will receive a significant&#xD;
      amount of ventricular pacing if programmed at physiologic AV intervals. As an alternative,&#xD;
      many pacemakers can be programmed to minimize ventricular pacing at the expense of allowing&#xD;
      longer AV delays. However, these long AV delays may not be physiologic and may also lead to&#xD;
      reduced cardiac output. At present the standard of care is either to program the pacemaker at&#xD;
      an physiologic &quot;natural&quot; AV delay of about 160 msec or to program the pacemaker with a long&#xD;
      AV delay to minimize ventricular pacing.&#xD;
&#xD;
      The main scientific questions being addressed in this study are to evaluate the acute and&#xD;
      chronic effects on cardiac output, functional status, sense of well-being, and cardiac&#xD;
      remodeling of a long AV delay allowing for intrinsic conduction as compared to an&#xD;
      echocardiographically optimized AV delay during dual chamber pacing.&#xD;
&#xD;
      Patients enrolled in the trial will complete a run-in period of two weeks prior to&#xD;
      randomization in which pacemakers will be programmed with a long-fixed AV delay to allow&#xD;
      intrinsic conduction and minimize ventricular pacing (standard). At two weeks, patients will&#xD;
      receive a baseline echocardiogram. To determine optimal AV delay, all patients will undergo&#xD;
      echocardiographic analysis at varying AV delays. Optimal AV delay will be defined as the AV&#xD;
      delay associated with the largest average aortic Doppler velocity time integral (VTI). Then,&#xD;
      patients will be randomized to either the short, optimized (experimental) or long, fixed&#xD;
      (standard) AV delay groups. To assess functional status and sense of well-being, patients&#xD;
      will complete a six minute walk test and Short Form-36 Medical Outcomes Study Questionnaire.&#xD;
      Patients return to clinic for another study visit at 6 months and repeat research procedures,&#xD;
      including baseline echocardiogram, questionnaire, and 6 minute walk test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2013</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cardiac output determined by echocardiography</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in functional status determined by 6 minute walk.</measure>
    <time_frame>6 months</time_frame>
    <description>Measure distance walked in 6 minutes in meters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in sense of well being as determined by Short Form - 36 Medical Outcomes Study Questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>Sense of well being score determined by answers to questions on Short Form - 36 questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Atrioventricular Block</condition>
  <condition>Sick Sinus Syndrome</condition>
  <condition>Symptomatic Bradycardia</condition>
  <condition>Cardiac Arrhythmia</condition>
  <arm_group>
    <arm_group_label>Long, fixed AV delay</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pacemaker will be set to a long, fixed AV delay to minimize ventricular pacing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Short, optimized AV delay</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pacemaker will be set to the AV delay that produces the greatest cardiac output in echocardiography for each patient enrolled</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Long, fixed AV delay</intervention_name>
    <description>Pacemaker will be set to a long, fixed AV delay to minimize ventricular pacing</description>
    <arm_group_label>Long, fixed AV delay</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Short, optimized AV delay</intervention_name>
    <description>Pacemaker will be set to the AV delay that produces the greatest cardiac output in echocardiography for each patient enrolled.</description>
    <arm_group_label>Short, optimized AV delay</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patient population: Individuals with 1st degree atrioventricular (AV) block who have&#xD;
        received a dual chamber pacemaker for symptomatic bradycardia.&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients greater than 18 years of age&#xD;
&#xD;
          2. Patients with symptomatic sinus bradycardia&#xD;
&#xD;
          3. Patients who meet standard indications for dual chamber pacemaker implantation&#xD;
&#xD;
          4. Patients who have 1st degree AV block determined by PR interval &gt; 200ms&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with complete or high grade AV block&#xD;
&#xD;
          2. Patients who are unable to complete dual chamber pacemaker implantation for any reason&#xD;
&#xD;
          3. Patients with congestive heart failure determined by a Left Ventricular Ejection&#xD;
             Fraction &lt; 45%&#xD;
&#xD;
          4. Patients with persistent atrial fibrillation&#xD;
&#xD;
          5. Sustained premature ventricular contractions (PVCs), premature atrial contractions&#xD;
             (PACs), atrial flutter, or other heart conditions that may interfere with&#xD;
             echocardiography measurements&#xD;
&#xD;
          6. Patients who are pregnant&#xD;
&#xD;
          7. Patients with Paroxysmal Atrial Fibrillation that have had an episode(s) within 30&#xD;
             days of consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory K Feld, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSD Electrophysiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSD Sulpizio Cardiovascular Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm. 2004 Nov;1(5):562-7.</citation>
    <PMID>15851220</PMID>
  </reference>
  <reference>
    <citation>Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol. 2009 Aug 25;54(9):764-76. doi: 10.1016/j.jacc.2009.06.006. Review.</citation>
    <PMID>19695453</PMID>
  </reference>
  <reference>
    <citation>Iliev II, Yamachika S, Muta K, Hayano M, Ishimatsu T, Nakao K, Komiya N, Hirata T, Ueyama C, Yano K. Preserving normal ventricular activation versus atrioventricular delay optimization during pacing: the role of intrinsic atrioventricular conduction and pacing rate. Pacing Clin Electrophysiol. 2000 Jan;23(1):74-83.</citation>
    <PMID>10666756</PMID>
  </reference>
  <reference>
    <citation>Sweeney MO, Ellenbogen KA, Tang AS, Whellan D, Mortensen PT, Giraldi F, Sandler DA, Sherfesee L, Sheldon T; Managed Ventricular Pacing Versus VVI 40 Pacing Trial Investigators. Atrial pacing or ventricular backup-only pacing in implantable cardioverter-defibrillator patients. Heart Rhythm. 2010 Nov;7(11):1552-60. doi: 10.1016/j.hrthm.2010.05.038. Epub 2010 Jun 4.</citation>
    <PMID>20685401</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 28, 2014</study_first_submitted>
  <study_first_submitted_qc>May 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Greg Feld</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Atrioventricular delay</keyword>
  <keyword>AV delay</keyword>
  <keyword>Pacemaker</keyword>
  <keyword>Sick Sinus Syndrome</keyword>
  <keyword>Bradycardia</keyword>
  <keyword>PR interval</keyword>
  <keyword>Atrioventricular block</keyword>
  <keyword>AV block</keyword>
  <keyword>Echocardiography</keyword>
  <keyword>Arrhythmia</keyword>
  <keyword>AV optimization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Bradycardia</mesh_term>
    <mesh_term>Atrioventricular Block</mesh_term>
    <mesh_term>Sick Sinus Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

